The request, also covering Novo's older weight-loss ‍drug, Saxenda, follows a review by ​the U.S. Food and Drug ...

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

Medications once used to treat illness are increasingly being taken for prevention. Experts explain what’s behind the ...

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...

The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...

Reading vitamin labels can sometimes be a mystifying experience. To help clarify, here are the various FDA vitamin labels and what they all mean.

If you have any Boar's Head or Member's Mark cheeses in your refrigerator, check to see if they have been recalled by the FDA ...

The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.

The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk’s Wegovy and ...

Questions about cost and patient benefit loom as Congress considers automatic Medicare coverage for 'breakthrough' medical ...

Argenx (ARGX) announced on Tuesday that the U.S. FDA has granted priority review for its marketing application aimed at ...